Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Aesthetic options, in addition to robust security features, are increasingly important to architectural door openings.Adams Rite delivers, expanding its finish offerings for the 8800 ...

Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

The Company will be focusing on the following programs with Bucillamine: Revive is targeting nerve agent exposure as its initial indication for its medical countermeasures program. Nerve agents are ...

United States Human Rights Violations against the Numu/Nuwu and Newe in the Rush for Lithium,” found that the US Bureau of ...

The new lineup of EV vans is based on an 800-volt skateboard platform developed by Renault's Ampere unit that is said to ...

By leveraging behavior and anticipatory frameworks and principles, UX designers can create AI-driven solutions that are ...

The company's $400 million restaurant concepts don’t share much in common. That’s exactly how CEO Jack Gibbons likes it.

Global gold and copper miner Barrick Gold Corporation has reported that its attributable proven and probable gold mineral reserves have increased by 17.4-million ounces before 2024 depletion.

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...